1. Home
  2. SANA vs REPX Comparison

SANA vs REPX Comparison

Compare SANA & REPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SANA
  • REPX
  • Stock Information
  • Founded
  • SANA 2018
  • REPX 2016
  • Country
  • SANA United States
  • REPX United States
  • Employees
  • SANA N/A
  • REPX N/A
  • Industry
  • SANA Medicinal Chemicals and Botanical Products
  • REPX Oil & Gas Production
  • Sector
  • SANA Health Care
  • REPX Energy
  • Exchange
  • SANA Nasdaq
  • REPX Nasdaq
  • Market Cap
  • SANA 519.8M
  • REPX 608.2M
  • IPO Year
  • SANA 2021
  • REPX N/A
  • Fundamental
  • Price
  • SANA $1.71
  • REPX $25.90
  • Analyst Decision
  • SANA Strong Buy
  • REPX Strong Buy
  • Analyst Count
  • SANA 5
  • REPX 1
  • Target Price
  • SANA $9.50
  • REPX $47.00
  • AVG Volume (30 Days)
  • SANA 4.1M
  • REPX 105.3K
  • Earning Date
  • SANA 05-07-2025
  • REPX 05-07-2025
  • Dividend Yield
  • SANA N/A
  • REPX 5.81%
  • EPS Growth
  • SANA N/A
  • REPX N/A
  • EPS
  • SANA N/A
  • REPX 4.26
  • Revenue
  • SANA N/A
  • REPX $410,181,000.00
  • Revenue This Year
  • SANA N/A
  • REPX $7.75
  • Revenue Next Year
  • SANA N/A
  • REPX $2.95
  • P/E Ratio
  • SANA N/A
  • REPX $6.15
  • Revenue Growth
  • SANA N/A
  • REPX 9.37
  • 52 Week Low
  • SANA $1.26
  • REPX $21.98
  • 52 Week High
  • SANA $10.50
  • REPX $37.55
  • Technical
  • Relative Strength Index (RSI)
  • SANA 45.52
  • REPX 46.29
  • Support Level
  • SANA $1.53
  • REPX $24.49
  • Resistance Level
  • SANA $1.92
  • REPX $25.96
  • Average True Range (ATR)
  • SANA 0.20
  • REPX 1.85
  • MACD
  • SANA 0.05
  • REPX 0.21
  • Stochastic Oscillator
  • SANA 68.18
  • REPX 62.92

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

About REPX Riley Exploration Permian Inc.

Riley Exploration Permian Inc is engaged in the business of exploration for and production of oil and natural gas. The company operations are in Kansas Properties, and Tennessee Properties, among others.

Share on Social Networks: